FH20 is essential for FH’s ability to distinguish host cells from pathogens:
Host Cell Protection: Binds to GAGs on host cells, positioning FH19 to inactivate surface-bound C3b via cofactor activity .
Pathogen Clearance: Fails to bind pathogen surfaces lacking GAGs, allowing complement activation .
Disease Link: Mutations in FH20 disrupt C3b binding, leading to uncontrolled complement activation and aHUS .
Mutation Hotspot: Over 50% of aHUS-linked FH mutations occur in SCR20, impairing C3b binding .
Functional Defects: Mutants like R1210C reduce C3b binding affinity by >90%, increasing complement-mediated endothelial damage .
Mechanistic Studies: Resolving how FH20 balances dual binding to C3b and GAGs could inform therapeutic design.
Antibody Engineering: Developing bispecific antibodies that enhance FH20’s protective role without triggering autoimmunity.